Vanderbilt Lung Institute

October 20, 2022

New target for lung fibrosis

Blocking thromboxane-prostanoid receptor signaling protected animals from lung fibrosis in preclinical models, suggesting a new treatment for IPF — a chronic, progressive lung disorder that often kills within 3-5 years of diagnosis.

By Leigh MacMillan
Mervyn Joseph traveled from South Africa to receive his lung transplant at Vanderbilt.
September 29, 2022

Patient journeys from South Africa for lung transplant

Mervyn Joseph, who searched the world over for the best place to be considered for lung transplant, is thankful he found Vanderbilt University Medical Center.

By Matt Batcheldor
December 16, 2021

AI used to identify patients at risk for lung cancer

By Matt Batcheldor
November 18, 2020

Collaborative Vanderbilt Lung Institute launches

By Matt Batcheldor